BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cabou C, Vachoux C, Campistron G, Drucker DJ, Burcelin R. Brain GLP-1 signaling regulates femoral artery blood flow and insulin sensitivity through hypothalamic PKC-δ. Diabetes 2011;60:2245-56. [PMID: 21810595 DOI: 10.2337/db11-0464] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Lovshin JA, Zinman B. Blood pressure-lowering effects of incretin-based diabetes therapies. Can J Diabetes. 2014;38:364-371. [PMID: 25284699 DOI: 10.1016/j.jcjd.2014.05.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
2 Farnsworth NL, Walter R, Piscopio RA, Schleicher WE, Benninger RKP. Exendin-4 overcomes cytokine-induced decreases in gap junction coupling via protein kinase A and Epac2 in mouse and human islets. J Physiol 2019;597:431-47. [PMID: 30412665 DOI: 10.1113/JP276106] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
3 Yang M, Wang J, Wu S, Yuan L, Zhao X, Liu C, Xie J, Jia Y, Lai Y, Zhao AZ, Boden G, Li L, Yang G. Duodenal GLP-1 signaling regulates hepatic glucose production through a PKC-δ-dependent neurocircuitry. Cell Death Dis 2017;8:e2609. [PMID: 28182013 DOI: 10.1038/cddis.2017.28] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
4 Pujadas G, Drucker DJ. Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical Relevance. Endocr Rev 2016;37:554-83. [PMID: 27732058 DOI: 10.1210/er.2016-1078] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
5 Fu Z, Gong L, Liu J, Wu J, Barrett EJ, Aylor KW, Liu Z. Brain Endothelial Cells Regulate Glucagon-Like Peptide 1 Entry Into the Brain via a Receptor-Mediated Process. Front Physiol 2020;11:555. [PMID: 32547420 DOI: 10.3389/fphys.2020.00555] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Li Y, Tian M, Yang M, Yang G, Chen J, Wang H, Liu D, Wang H, Deng W, Zhu Z, Zheng H, Li L. Central Sfrp5 regulates hepatic glucose flux and VLDL-triglyceride secretion. Metabolism 2020;103:154029. [PMID: 31770545 DOI: 10.1016/j.metabol.2019.154029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
7 Goud A, Zhong J, Peters M, Brook RD, Rajagopalan S. GLP-1 Agonists and Blood Pressure: A Review of the Evidence. Curr Hypertens Rep 2016;18. [DOI: 10.1007/s11906-015-0621-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
8 Helmstädter J, Keppeler K, Küster L, Münzel T, Daiber A, Steven S. Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor. Br J Pharmacol 2021. [PMID: 33764504 DOI: 10.1111/bph.15462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bakbak E, Terenzi DC, Trac JZ, Teoh H, Quan A, Glazer SA, Rotstein OD, Al-Omran M, Verma S, Hess DA. Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease? Rev Endocr Metab Disord 2021. [PMID: 34228302 DOI: 10.1007/s11154-021-09669-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Shi X, Chacko S, Li F, Li D, Burrin D, Chan L, Guan X. Acute activation of GLP-1-expressing neurons promotes glucose homeostasis and insulin sensitivity. Mol Metab 2017;6:1350-9. [PMID: 29107283 DOI: 10.1016/j.molmet.2017.08.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
11 Grasset E, Puel A, Charpentier J, Collet X, Christensen JE, Tercé F, Burcelin R. A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism. Cell Metabolism 2017;25:1075-1090.e5. [DOI: 10.1016/j.cmet.2017.04.013] [Cited by in Crossref: 98] [Cited by in F6Publishing: 94] [Article Influence: 19.6] [Reference Citation Analysis]
12 Sandoval D, Sisley SR. Brain GLP-1 and insulin sensitivity. Mol Cell Endocrinol 2015;418 Pt 1:27-32. [PMID: 25724479 DOI: 10.1016/j.mce.2015.02.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
13 Duca FA, Yue JT. Fatty acid sensing in the gut and the hypothalamus: in vivo and in vitro perspectives. Mol Cell Endocrinol 2014;397:23-33. [PMID: 25261798 DOI: 10.1016/j.mce.2014.09.022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
14 Heni M, Kullmann S, Gallwitz B, Häring HU, Preissl H, Fritsche A. Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans. Mol Metab 2015;4:971-6. [PMID: 26909313 DOI: 10.1016/j.molmet.2015.09.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
15 Gatford KL, Sulaiman SA, Mohammad SN, De Blasio MJ, Harland ML, Simmons RA, Owens JA. Neonatal exendin-4 reduces growth, fat deposition and glucose tolerance during treatment in the intrauterine growth-restricted lamb. PLoS One 2013;8:e56553. [PMID: 23424667 DOI: 10.1371/journal.pone.0056553] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
16 Yue JTY, Abraham MA, Lapierre MP, Mighiu PI, Light PE, Filippi BM, Lam TKT. A fatty acid-dependent hypothalamic–DVC neurocircuitry that regulates hepatic secretion of triglyceride-rich lipoproteins. Nat Commun 2015;6. [DOI: 10.1038/ncomms6970] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
17 Su CM, Hsu CJ, Tsai CH, Huang CY, Wang SW, Tang CH. Resistin Promotes Angiogenesis in Endothelial Progenitor Cells Through Inhibition of MicroRNA206: Potential Implications for Rheumatoid Arthritis. Stem Cells 2015;33:2243-55. [PMID: 25828083 DOI: 10.1002/stem.2024] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
18 Pedroso JA, Buonfiglio DC, Cardinali LI, Furigo IC, Ramos-Lobo AM, Tirapegui J, Elias CF, Donato J Jr. Inactivation of SOCS3 in leptin receptor-expressing cells protects mice from diet-induced insulin resistance but does not prevent obesity. Mol Metab 2014;3:608-18. [PMID: 25161884 DOI: 10.1016/j.molmet.2014.06.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
19 Nandy D, Johnson C, Basu R, Joyner M, Brett J, Svendsen CB, Basu A. The effect of liraglutide on endothelial function in patients with type 2 diabetes. Diabetes and Vascular Disease Research 2014;11:419-30. [DOI: 10.1177/1479164114547358] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
20 Sheikh A. Direct cardiovascular effects of glucagon like peptide-1. Diabetol Metab Syndr 2013;5:47. [PMID: 23988189 DOI: 10.1186/1758-5996-5-47] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
21 Gupta NA, Kolachala VL, Jiang R, Abramowsky C, Romero R, Fifadara N, Anania F, Knechtle S, Kirk A. The glucagon-like peptide-1 receptor agonist Exendin 4 has a protective role in ischemic injury of lean and steatotic liver by inhibiting cell death and stimulating lipolysis. Am J Pathol. 2012;181:1693-1701. [PMID: 22960075 DOI: 10.1016/j.ajpath.2012.07.015] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
22 Jiang Y, Wang Z, Ma B, Fan L, Yi N, Lu B, Wang Q, Liu R. GLP-1 Improves Adipocyte Insulin Sensitivity Following Induction of Endoplasmic Reticulum Stress. Front Pharmacol 2018;9:1168. [PMID: 30459598 DOI: 10.3389/fphar.2018.01168] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
23 Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 2013;17:819-837. [PMID: 23684623 DOI: 10.1016/j.cmet.2013.04.008] [Cited by in Crossref: 768] [Cited by in F6Publishing: 694] [Article Influence: 85.3] [Reference Citation Analysis]
24 Yue JT, Lam TK. Lipid sensing and insulin resistance in the brain. Cell Metab. 2012;15:646-655. [PMID: 22560217 DOI: 10.1016/j.cmet.2012.01.013] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
25 Liu X, Wang Z, Wang P, Yu B, Liu Y, Xue Y. Green tea polyphenols alleviate early BBB damage during experimental focal cerebral ischemia through regulating tight junctions and PKCalpha signaling. BMC Complement Altern Med 2013;13:187. [PMID: 23870286 DOI: 10.1186/1472-6882-13-187] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
26 Cheng Y, Miller MJ, Zhang D, Xiong Y, Hao Y, Jia C, Cai T, Li SH, Johansson US, Liu Y, Chang Y, Song G, Qu Y, Lei F. Parallel genomic responses to historical climate change and high elevation in East Asian songbirds. Proc Natl Acad Sci U S A 2021;118:e2023918118. [PMID: 34873033 DOI: 10.1073/pnas.2023918118] [Reference Citation Analysis]
27 Cabou C, Burcelin R. GLP-1, the gut-brain, and brain-periphery axes. Rev Diabet Stud. 2011;8:418-431. [PMID: 22262078 DOI: 10.1900/rds.2011.8.418] [Cited by in Crossref: 49] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
28 Rasmussen BA, Breen DM, Lam TK. Lipid sensing in the gut, brain and liver. Trends Endocrinol Metab 2012;23:49-55. [PMID: 22169756 DOI: 10.1016/j.tem.2011.11.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
29 Zampieri TT, Ramos-Lobo AM, Furigo IC, Pedroso JA, Buonfiglio DC, Donato J Jr. SOCS3 deficiency in leptin receptor-expressing cells mitigates the development of pregnancy-induced metabolic changes. Mol Metab 2015;4:237-45. [PMID: 25737950 DOI: 10.1016/j.molmet.2014.12.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
30 Gao X, Lindqvist A, Sandberg M, Groop L, Wierup N, Jansson L. Effects of GIP on regional blood flow during normoglycemia and hyperglycemia in anesthetized rats. Physiol Rep 2018;6:e13685. [PMID: 29673130 DOI: 10.14814/phy2.13685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]